XENE

NASDAQXenon Pharmaceuticals Inc
Calm Tide · 34Squeeze · Idle 27Neutral0 buys · $0Social · No data 0
$59.55
$-0.20 (-0.33%)
15-min delayed · Sep 9, 2:10 AMReal-time

Score summary

Strong Buy
Analyst Ratings
10Ratings
10 Buy0 Hold0 Sell
Tide Score
34
Calm Tide · stable · Bottom 13% of universe (3990)
Outlook29Calm Tide · stable · Bottom 7% of universe (3991)
Squeeze Score
27
Idle ·
  • Days to cover9.16
  • Short interest4.30% of float
  • Borrow rate42.35%
  • Short interest trend+0.29% (30d)
Trend
Neutral
No clear trend (signals split)
Recent Smart Money
0 buys
Quiet · $0 · 14d · 4 super investors

Key statistics

Market Cap
$5.79B
52-week range
$35.66 – $70.96
68% from low
Day range
$59 – $61
Open $60.02
Volume
459k
vs 640k avg · 72%
P/E (TTM)
Fwd —
Earnings
Nov 2
54d

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 10 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$76
10 Wall St 12-month targets
High
$97
Average
$75
Low
$55
$49$62$74$86$99HIGH$97MEDIAN$76LOW$55Mar ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 75/100 Analyst Score (Strong Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Nov 2 · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.